Showcases Stock ranks Forex

Merck & Company (MRK)
104.8  0.57 (0.55%) 03-24 16:03
Open: 104.09 Pre. Close: 104.23
High: 105.01 Low: 102.44
Volume: 6,658,529 Market Cap: 266,044(M)
Stock Technical Analysis
Target: Six months: 126.68
One year: 131.03
Support: Support1: 102.44
Support2: 85.23
Resistance: Resistance1: 108.46
Resistance2: 112.18
Pivot: 106.84
Moving Averages: MA(5): 104.96
MA(20): 106.93
MA(100): 107.43
MA(250): 96.66
MACD: MACD(12,26): -0.92
Signal(12,26,9): -0.59
%K %D: %K(14,3): 14.53
%D(3): 16.44
RSI: RSI(14): 42.99
52-Week: High: 115.49
Low: 80.45
Change(%): 27.2
Average Vol(K): 3-Month: 8447
10-Days: 8865
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 105.059 - 105.694 105.694 - 106.302
Low: 100.947 - 101.69 101.69 - 102.402
Close: 103.647 - 104.755 104.755 - 105.817
Price, MAs and Bollinger Bands
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.

[ MRK ] has closed above bottom band by 26.5%. Bollinger Bands are 14.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Company profile
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Stock chart
Stock News
Sat, 25 Mar 2023
Women's Lacrosse: Merck's career-high lifts Norwich over Falcons ... -

Fri, 24 Mar 2023
Moody's affirms Merck & Co.'s A1 rating; revises outlook to stable ... - Moody's

Thu, 23 Mar 2023
Merck Presents its Latest Cosmetics Innovations at “in-cosmetics ... - Merck KGaA

Wed, 22 Mar 2023
These 4 Measures Indicate That Merck (NYSE:MRK) Is Using Debt Safely - Simply Wall St

Wed, 22 Mar 2023
Merck Biomanufacturing Optimization Sees Major Production Gains - Genetic Engineering & Biotechnology News

Tue, 21 Mar 2023
Top Research Reports for Merck, Intel & MercadoLibre - Yahoo Finance

Financial Analysis
Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. (M) 2540.00
Shares Float (M) 2540.00
% Held by Insiders 0.10
% Held by Institutions 77.66
Shares Short (K) 20550
Shares Short Prior Month (K) 17150
Stock Financials
EPS 5.530
Book Value (p.s.) 18.120
Profit Margin 24.49
Operating Margin 34.69
Return on Assets (ttm) 12.0
Return on Equity (ttm) 34.5
Qtrly Rev. Growth 2.3
Gross Profit (p.s.) 16.567
Sales Per Share 23.339
EBITDA (p.s.) 9.587
Qtrly Earnings Growth -20.00
Operating Cash Flow (M) 19090.00
Levered Free Cash Flow (M) 12690.00
Stock Valuation
PE Ratio 18.95
PEG Ratio 1.49
Price to Book value 5.78
Price to Sales 4.49
Price to Cash Flow 13.94
Stock Dividends
Dividend 0.730
Dividend Yield 0.01
Dividend Growth

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android